Lim et al.Authors' Reply Tae Seop Lim, Sujin Kwon, Sung A Bae, Hye Yeon Chon, Seol A
First, it directly addresses the root cause of mast cell hyper-reactivity: intracellular oxidative stress
The semaglutide and tirzepatide molecules are the same, so transitioning at the same dose is typically straightforward
Participants should follow the instructions provided by their trial site and return unused product to the trial team rather than disposing of it independently
Consequently, these errors create confounding variables that quickly invalidate experimental data
These include diet, lack of sleep, stress, genetics, and especially exposure to the damaging rays of sunlight that have been reviewed in detail elsewhere and will be presented, in brief, below [10, 14, 16]